|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08037 CH BIOTECH SER
Nominal 
1.070 +0.020 (+1.905%) | 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | |
| Turnover | 38,872 | 19.794% | 32,449 | 182,357 | 686,909 | 374,159 |
| Cost of Sales | (36,330) | 2.177% | (35,556) | (121,031) | (332,005) | (157,601) |
| Gross Profit | 2,542 | -- | (3,107) | 61,326 | 354,904 | 216,558 |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (5,315) | -- | 3,016 | 14,854 | 2,690 | (1,311) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | 1,696 | (507) | |
| Other Non-operating Items | -- | -- | -- | (26) | (1,527) | (2,687) | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | (2,771) | (1,032) | 0 | |
| Profit / (Loss) before Taxation | (37,159) | -70.569% | (126,258) | (24,677) | 253,756 | 138,703 | |
| Taxation | 406 | -22.960% | 527 | (3,044) | (47,396) | (29,713) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 4,747 | -89.639% | 45,814 | (2,763) | (138,140) | (84,751) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (32,006) | -59.951% | (79,917) | (30,484) | 68,220 | 24,239 | |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | |
| Net Finance Costs / (Income) | 12,525 | 195.053% | 4,245 | 1,026 | 2,294 | 4,071 |
| Depreciation & Amortisation | 7,317 | -43.297% | 12,904 | 35,346 | 33,341 | 33,986 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | -3.300 | -60.241% | -8.300 | -3.200 | 7.100 | 2.500 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.245 | -- | 0.405 | 0.565 | 0.443 | 0.387 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -32,006 |
| %Change | -59.951% |
| EPS / (LPS) | HKD -0.033 |
| NBV Per Share ($) | HKD 0.245 |